We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image Credit: Adobe Stock

Genomic Tissue Test Predicts Metastasis and Abiraterone Benefit in High-Risk Prostate Cancer

A tissue-based molecular test stratifies prostate cancer spread risk and identifies patients who may benefit from therapy.

More...
27 Oct 2026
Photo courtesy of Tempus AI

RNA Sequencing Assay Gains EU Certification for Solid Tumor Profiling

The Tempus xR assay has received certification under the EU’s IVDR as a Class C in vitro diagnostic device. More...
27 Oct 2026
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

New findings show that sustained decentralized laboratories enable 24-hour viral hemorrhagic fever testing. More...
27 Oct 2026
Image: New research shows that human lung cancers use a process called alternative RNA splicing to produce different versions (isoforms) of the immune-alarm gene STAT2, shown here as ribbons. Isoforms of STAT2 are associated with how well lung cancer patients respond to immunotherapy: an isoform that retains an extra segment called an intron (top ribbon) is found in patients who respond to anti-PD-L1, while an isoform without it (bottom ribbon) is found in nonresponders. These splicing signatures could one day help doctors predict, before treatment begins, which patients are most likely to benefit from immunotherapy. (Photo courtesy of The Jackson Laboratory)

Lung Tumor RNA Variants Offer Clues to Immunotherapy Benefit

Researchers identify gene activity patterns linked to immunotherapy response in lung cancer. More...
27 Oct 2026
Image: Spleen tissue from a mouse without PHF19 (left) and a mouse with normal PHF19 function (right). Dense clusters of immune cells sit within blood-rich regions in pink. Without PHF19, cells are altered in their differentiation process (Photo courtesy of Gianni Gamarra/Centro de Regulación Genómica)

Six-Gene Score Improves Prognosis Prediction in Acute Myeloid Leukemia

Researchers identify a six-gene AML score that more accurately predicts survival and may simplify prognostic testing. More...
26 Oct 2026
Image Credit: iStock

Long-Read Sequencing Reveals Cancer-Driving Changes Missed by Conventional Testing

Long-read sequencing reveals hidden cancer-driving changes missed by conventional methods, offering a clearer view of tumor genetics. More...
26 Oct 2026
Image: Abbott has launched its next-generation Oncodetect MRD test, a personalized whole-genome sequencing assay for molecular monitoring during and after cancer treatment. (Photo courtesy of Abbott)

Whole-Genome MRD Test Detects Traces of Cancer During and After Treatment

Abbott has announced the commercial availability of its next-generation Oncodetect MRD test for patients with solid tumors. More...
26 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT